Table 1.
Methodological characteristics of included studies
First author— tendinopathy | Study type | Randomisation method | Blinding method | Allocation concealment | Statistical power calculation | Baseline comparison | Inclusion criteria | Exclusion criteria | Follow-up completion |
Brox36— Shoulder |
Randomised controlled trial | Random permuted blocks | Patients wearing t-shirts at follow-up to hide scar; patients asked not to talk to assessor about treatment | – | Yes, 90% | Less women in surgery group | Age 18–66 y, shoulder pain for >3 m, resistant to physio and drugs, dysfunction/pain on abduction, normal passive ROM, pain during two of the three isometric-eccentric tests, positive impingement tests | Acromioclavicular joint arthritis, cervical syndrome, rotator cuff rupture, glenohumeral instability, bilateral muscular pain with tenderness and severely decreased ability to relax the shoulder/neck/temporomandibular joint on examination, reluctant to accept one or more of the treatment regimens of the study | 99% |
Rahme37
—Shoulder |
Randomised controlled trial | Blocked randomisation | Independent assessor | – | No | No comparison | Isolated shoulder disease, working age, shoulder pain >1 y at rest accentuated by movements involving elevation, positive Hawkins (impingement) sign, positive impingement test (relief of symptoms within 15 min of injection of local anaesthetic) | Glenohumeral osteoarthritis, those requiring resection of the lateral end of the clavicle | 93% |
Rompe30— Shoulder |
Randomised trial (non-controlled) | Based on whether reimbursement for ESWT was approved by insurance company | Not blinded | – | – | No differences | Calcareous deposit on standard AP radiographs of a diameter of at least 10 mm; the morphological features of the deposit had to be homogeneous in appearance and with well-defined borders, or inhomogeneous in structure with sharp outline or homogeneous in structure with no defined border, shoulder pain for more than 12 m, clinical signs of subacromial impingement, unsuccessful conservative therapy in the previous 6 m, no evidence of bone-related anatomic outlet impingement or functional outlet impingement as seen on radiographs or MRI | Cloudy and transparent appearance of deposit, radiological signs of spontaneous resorption, evidence of type III acromial morphological feature according to Bigliani et al on the outlet view of the acromion, evidence of subacute acromial bursitis, evidence of acromial spur or acromioclavicular osteophytes on AP radiographs, evidence of rotator cuff tears on MRI, evidence of functional impingement of rotator cuff on USS or arthroMRI, tears of the glenohumeral ligaments of the labrum, hypertrophy of supraspinatus muscle, dysfunction in neck or thoracic region, prior shoulder surgery, local degenerative disease of shoulder, RA, neurological abnormalities of the upper limb with calcifying tendinitis, pregnancy, infection, tumour | 75% |
Haahr35— Shoulder |
Randomised controlled trial | Computer-generated random sequence generation | Not blinded | Sealed envelopes | Yes, 80% | More sick leave due to more severe shoulder pain in surgery group | Fulfilment of all diagnostic criteria (shoulder pain, pain on abduction with painful arc, Hawkins sign, positive impingement test (relief of symptoms within 15 min of injection of local anaesthetic), symptoms 6 m–-3 y, age 18–55 y, normal passive glenohumeeal movements | Impaired glenohumeral rotation, history of acute trauma, previous surgery of fracture near affected shoulder, known OA in glenohumeral or acromioclavicular joint, clacifications >2 cm in rotator cuff tendons, rupture of the cuff, cervical root syndromes | 93% |
Ketola29 — Shoulder |
Randomised controlled trial | Computer-generated numbers | Independent physiotherapist conducted 5-year assessment; participants wearing t-shirts to cover scars and asked not to indicate treatment group | Randomisation by independent statistician; sealed envelopes |
Yes, 80% | No difference in outcome measures, no comparison of demographics | Clinical symptoms of shoulder impingement, positive Neer’s test, symptoms for at least 3 m, failed management with rest, NSAIDs, steroid injections and regular physiotherapy, age 18–60 y, no previous shoulder operations, willingness and capacity to comply with study protocol | OA, glenohumeral instability, penetrating rotator cuff rupture, cervical radiculopathy, adhesive capsulitis, shoulder neuropathy | 78% |
Farfaras28—Shoulder | Randomised controlled trial | Envelopes divided in boxes based on sex and age | Independent physiotherapist conducted assessment; participants encouraged to wear a t-shirt at follow-up to conceal their scar | – | Yes, sample size not enough for 80% power | No difference | Positive Neer and Hawkins tests, failed conservative management, subacromial pain for more than 6 m | Diabetes mellitus, neurological or spine disorders, radiographic OA, chronic joint disorders, full-thickness rotator cuff tear, subacromial impingement syndrome stage 3 | 63% |
Beard34— Shoulder |
Randomised controlled trial | Automated computer-generated minimisation system | Double blinded except ‘no treatment’ group; masked assessment |
Centralised telephone randomisation centre used | Yes, 90% | No difference | Subacromial pain for at least 3 m, consultant’s clinical diagnosis, eligible for arthroscopic surgery, completion of conservative management programme including physiotherapy and at least one steroid injection | Full-thickness rotator cuff tear, other shoulder pathology identified on MRI or USS, previous shoulder surgery on affected side, RA or other inflammatory joint conditions, cervical spine pathology, previous septic arthritis in shoulder, radiotherapy in same side as affected shoulder, lacking consent, cognitive impairment or language issues, unable to perform clinical assessments, >75 y of age | 81% |
Bahr27— Patella |
Randomised controlled trial | Randomisation sequence in blocks of four created by statistician; those who had failed eccentric strengthening were allocated to secondary surgery group | Not blinded | Sealed envelopes; randomisation sequence created by statistician |
Yes, 90% | No differences | History of exercise-related pain in proximal patellar tendon or patellar insertion and tenderness to palpation, pain during and after activity and unable to participate in sports at same level as before onset of pain, thickening and increased signal intensity on MRI | History of knee/patellar tendon surgery, inflammatory or degenerative joint condition, less than 18 y of age, inability to understand oral and written Norwegian | 88% |
Alfredson33— Achilles |
Randomised trial (non-controlled) | Box with envelopes | Not blinded | Opaque envelopes | No | No comparison as information not provided | – | – | 95% |
Radwan31— Lateral elbow |
Randomised trial (non-controlled) | Closed envelopes | Not blinded | Closed envelopes | Yes, 80% | Characteristics of two groups presented but comparison not performed | Established diagnosis of lateral epicondylitis with failure of conservative Tx for 6 m (NSAIDs, steroid injections, physical therapy, exercise programme, elbow brace) Pain induced by >1 of palpation of lateral epicondyle, resisted wrist extension, chair test |
Younger than 18 y, local infection, malignancy, elbow arthritis, generalised polyarthritis, ipsilateral shoulder dysfunction, neurological abnormalities, radial nerve entrapment, cardiac arrhythmia, pacemaker, steroid injection last 6 w, pregnancy | 89% |
Kroslak22— Lateral elbow |
Randomised controlled trial | Computer-generated code | Double blinded | Sealed, unmarked envelopes | Yes, 90% but not enough participant recruited | >18 y of age, clinical diagnosis lateral epicondylitis (point tenderness over lateral epicondyle and worse pain with chair pick-up test and maximal hand grip), failed conservative therapy for 6 m (including injections) | Previous surgery or dislocation of affected elbow, steroid injection in last 3 m, inadequate skin coverage over elbow, sensory/motor changes distal to elbow, unwillingness/inability to attend follow-up or enter either treatment arm | 85% (42% for clinical assessment) |
AP, antero-posterior;ESWT, extracorporeal shock wave therapy;m, months; MRI; magnetic resonance imaging; NSAIDs, non-steroidal anti-inflammatory drugs;OA, osteoarthritis;RA, rheumatoid arthritis;ROM, range of movement;USS, ultrasound scan;w, weeks;y, years.